- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

AstraZeneca’s Fasenra eliminates oral corticosteroids use in asthma trial

Frequent use of OCS can lead to serious adverse effects in asthma patients. Credit: BruceBlaus